2020: The Year in Experimental Medicine
In addition to host-pathogen interaction, this collection also includes new inroads in cancer immunology and immunotherapy, Alzheimer’s disease and aging-associated cognitive decline, adaptive immunity, normal and malignant hematopoiesis.
We are proud to present our annual Best of JEM series, featuring articles that were of great interest to our readers. In a year defined by the COVID-19 crisis, the cover of our collection is a tribute to the scientific community collectively confronting SARS-CoV-2 and searching for solutions, even as labs navigated myriad safety precautions and campus closures. Indeed, JEM editorial and staff members have been working remotely in line with worldwide efforts to contain the spread of the virus, as have many of our reviewers who have helped to ensure that publication of vital research continues. Articles related to COVID-19 and SARS-CoV-2 have been and will always be immediately free to read, as they continue to contribute to our understanding of one of the greatest international health crises we have ever faced.
The top ten papers were selected by the editorial team based, in part, on the number of requests for PDF and full-text HTML versions of an article in the first three months after publication. We hope you will enjoy this collection and encourage your feedback on Twitter at @JExpMed or email us at jem@rockefeller.edu. Sign up for special collections and announcements here.
Image by Neil Smith, neil@neilsmithillustration.co.uk
